Beta-adrenergic blockade in clinical practice.
Although all beta-blocking agents have similar pharmacologic effects, they have vastly different pharmacokinetic properties, which can influence the clinical usefulness of a given beta blocker in an individual patient. The efficacy of these drugs in a host of disorders-both cardiovascular and noncardiovascular-and their modes of action in these clinical contexts are examined and discussed.
D000319:Adrenergic beta-Antagonists / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D001008:Anxiety Disorders / Q000188:drug therapy; D002318:Cardiovascular Diseases / Q000188:drug therapy; D005901:Glaucoma / Q000188:drug therapy; D006261:Headache / Q000188:drug therapy; D006321:Heart / Q000187:drug effects; D006801:Humans; D007700:Kinetics; D013566:Sympathomimetics / Q000494:pharmacology / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D013566:Sympathomimetics